Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 610

1.

Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.

Overbosch D, Schilthuis H, Bienzle U, Behrens RH, Kain KC, Clarke PD, Toovey S, Knobloch J, Nothdurft HD, Shaw D, Roskell NS, Chulay JD; Malarone International Study Team.

Clin Infect Dis. 2001 Oct 1;33(7):1015-21. Epub 2001 Sep 5.

PMID:
11528574
2.

Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travelers: results of an international, randomized, open-label study.

Camus D, Djossou F, Schilthuis HJ, Høgh B, Dutoit E, Malvy D, Roskell NS, Hedgley C, De Boever EH, Miller GB; International Malarone Study Team.

Clin Infect Dis. 2004 Jun 15;38(12):1716-23. Epub 2004 May 27.

PMID:
15227617
3.

Atovaquone + proguanil: new preparation. Second-line antimalarial combination.

[No authors listed]

Prescrire Int. 2002 Oct;11(61):131-6.

PMID:
12378742
4.
5.

Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand.

Looareesuwan S, Wilairatana P, Chalermarut K, Rattanapong Y, Canfield CJ, Hutchinson DB.

Am J Trop Med Hyg. 1999 Apr;60(4):526-32.

PMID:
10348224
6.

The safety of atovaquone/proguanil in long-term malaria prophylaxis of nonimmune adults.

Petersen E.

J Travel Med. 2003 May;10 Suppl 1:S13-5; discussion S21.

7.

Atovaquone plus chloroguanide versus mefloquine for malaria prophylaxis: a focus on neuropsychiatric adverse events.

van Riemsdijk MM, Sturkenboom MC, Ditters JM, Ligthelm RJ, Overbosch D, Stricker BH.

Clin Pharmacol Ther. 2002 Sep;72(3):294-301.

PMID:
12235450
8.

Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.

Ling J, Baird JK, Fryauff DJ, Sismadi P, Bangs MJ, Lacy M, Barcus MJ, Gramzinski R, Maguire JD, Kumusumangsih M, Miller GB, Jones TR, Chulay JD, Hoffman SL; Naval Medical Research Unit 2 Clinical Trial Team.

Clin Infect Dis. 2002 Oct 1;35(7):825-33. Epub 2002 Sep 11.

PMID:
12228819
9.

Efficacy and safety of atovaquone-proguanil compared with mefloquine in the treatment of nonimmune patients with uncomplicated P. falciparum malaria in Japan.

Hitani A, Nakamura T, Ohtomo H, Nawa Y, Kimura M.

J Infect Chemother. 2006 Oct;12(5):277-82. Epub 2006 Nov 6.

PMID:
17109092
10.

Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group.

Looareesuwan S, Chulay JD, Canfield CJ, Hutchinson DB.

Am J Trop Med Hyg. 1999 Apr;60(4):533-41. Review.

PMID:
10348225
12.

The safety and tolerance of atovaquone/proguanil for the long-term prophylaxis of plasmodium falciparum malaria in non-immune travelers and expatriates [corrected].

van Genderen PJ, Koene HR, Spong K, Overbosch D.

J Travel Med. 2007 Mar-Apr;14(2):92-5. Erratum in: J Travel Med. 2007 May-Jun;14(3):203.

13.
14.

Atovaquone-proguanil (malarone): an effective treatment for uncomplicated Plasmodium falciparum malaria in travelers from Denmark.

Thybo S, Gjorup I, Ronn AM, Meyrowitsch D, Bygberg IC.

J Travel Med. 2004 Jul-Aug;11(4):220-3.

15.

Safety and efficacy of atovaquone and proguanil hydrochloride for the prophylaxis of Plasmodium falciparum malaria in South Africa.

van der Berg JD, Duvenage CS, Roskell NS, Scott TR.

Clin Ther. 1999 Apr;21(4):741-9.

PMID:
10363739
16.

Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria.

Shanks GD, Gordon DM, Klotz FW, Aleman GM, Oloo AJ, Sadie D, Scott TR.

Clin Infect Dis. 1998 Sep;27(3):494-9.

PMID:
9770146
17.
18.

[Atovaquone/proguanil. Prophylaxis and treatment of malaria].

Lundgren JD, Dragsted UB.

Ugeskr Laeger. 2000 Jul 31;162(31):4177-81. Review. Danish.

PMID:
10962933
19.

Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Malarone International Study Team.

Høgh B, Clarke PD, Camus D, Nothdurft HD, Overbosch D, Günther M, Joubert I, Kain KC, Shaw D, Roskell NS, Chulay JD; Malarone International Study Team.

Lancet. 2000 Dec 2;356(9245):1888-94.

PMID:
11130385
20.

[symbol: see text] Atovaquone + proguanil for malaria prophylaxis.

[No authors listed]

Drug Ther Bull. 2001 Oct;39(10):73-5. Review.

PMID:
11706518

Supplemental Content

Support Center